논문KCI 등재
TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (20)
관련 논문AI추천
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”Baokai Sun, Likun Zhuang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLDBaokai Sun, Jie Tan, Jie Zhang, Likun Zhuang, Shiying Xuan, Shousheng Liu, Shuimi Zhang, Xiaoqian Ding, Xueru Chu, Yongning Xin, Zhenzhen Zhao대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver DiseaseGeorge Boon-Bee Goh, Yiying Pei거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제1호Macrophage ATG16L1: Potential candidate for metabolic dysfunction-associated steatohepatitis treatment: Editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”Junjie Yu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Stabilizing hepatic fatty acid oxidation: Editorial on “USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination”Ja Hyun Koo, Myeung Gi Choi, Na Young Lee대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (84건)
Roles of X-box binding protein 1 in liver pathogenesisYun Seok Kim, Jihoon Tak, Sang Geon Kimpp. 1-31Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screeningTian Xia, Jiawen Wangpp. 1-2KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025Eun Joo Lee, Jung Hee Kim, Byoung Kuk Jang, Miyoung Choi, Su Jong Yu, Young-Sun Lee, Young-Joo Jin, Hye Won Lee, Soon Sun Kim, Pil Soo Sung, Young Kul Jung, Gi-Ae Kim, Young Chang, Won Sohn, Jeong-ju Yoopp. 1-31Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHua Lu, Xiao-Song Li, Xi-Ping Shen, Hang Lipp. 3-4Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adultsDonghee Kim, Aijaz Ahmed, Won Kimpp. 5-7